Pharmaceuticals
Saturday May 10
Barr sees downturn for 1Q
“While our results for the quarter did not meet our expectations, we believe that these results will improve in the second half of the year and demonstrate the value of expanding our operations and markets outside the U.S.”
Slowing sales for its generic products prompted Duramed Pharmaceuticals parent Barr Pharmaceuticals Inc. via Bizjournals
Posted by roboblogger
Full Story: Bizjournals
Complete Coverage: 4 stories
- The Patent Trader - Barr Pharmaceuticals boss promises earnings will improve
- The Journal News - Barr Pharmaceuticals boss promises earnings will improve
- Cincinnati Business Courier - Barr sees downturn for 1Q
- 1 more...
Related Topix
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| WVU faculty unmoved by president's remarks | May 15 | nancy | 1 |
| Study links drug to higher death rate in heart ... | May 15 | Tudo | 1 |
| Teva Announces Launch of Generic Protonix Table... | May 12 | Elizabeth | 11 |
| Teva Announces Launch of Generic Zoloft (from Nov '06) | May 12 | Cindy-Kate | 1054 |
| Drug Safety Information | May 9 | rudolph | 2 |
| Barr launches generic Actiq (from Oct '06) | May 8 | Elaine | 23 |
| W.Va.U. embroiled in scandal over degree for go... | May 7 | hub | 3 |
